Palliativ behandling av malign obstruksjon i mage-tarmkanal
Sist revidert:
Sist revidert av:Kristian Jansen
- Nasjonalt handlingsprogram for palliasjon i kreftomsorgen. IS-2285. Helsedirektoratet. Oslo 2015
- Bække J, Meisner S, Hvarness Bentsen H. Lindring af palliative patienters gastrointestinale symptomer. Ugeskr Læger 2007; 169: 3759. Ugeskrift for Læger
- Reijm AN, Didden P, Schelling SJC, et al.. Self-expandable metal stent placement for malignant esophageal strictures - changes in clinical outcomes over time. Endoscopy. 2019 Jan;51(1):18-29. Epub 2018 Jul 10. PMID: 29991071 PubMed
- Nasjonalt handlingsprogram for palliasjon i kreftomsorgen. IS-2285. Helsedirektoratet. Oslo 2015.
- Jeurnink SM, Steyerberg EW, Hof G, et al. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol 2007; 96: 389-96 PubMed
- Borowiec AM, Wang CS, Yong E, Law C, Coburn N, Sutradhar R, Baxter N, Paszat L, Tinmouth J. Colonic Stents for Colorectal Cancer Are Seldom Used and Mainly for Palliation of Obstruction: A Population-Based Study. Can J Gastroenterol Hepatol. 2016;2016:1945172. Epub 2016 Mar 29. PMID: 27446826 PubMed
- van Hooft JE, Bemelman WA, Oldenburg B, Marinelli AW, Lutke Holzik MF, Grubben MJ, Sprangers MA, Dijkgraaf MG, Fockens P; collaborative Dutch Stent-In study group. Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial. Lancet Oncol. 2011 Apr;12(4):344-52. Erratum in: Lancet Oncol. 2011 May;12(5):418. PMID: 21398178 PubMed
- Davis M, Hui D, Davies A, Ripamonti C, Capela A, DeFeo G, Del Fabbro E, Bruera E. Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update. Support Care Cancer. 2021 Dec;29(12):8089-8096. Epub 2021 Aug 14. PMID: 34390398 PubMed
- Mystakidou K, Tsilika E, Kalaidopoulou O et al. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer. Anticancer Res 2002; 22: 1187-92. PubMed
- Kristian Jansen, spesialist i allmennmedisin, PhD, kompetanseområde i alders- og sykehjemsmedisin, Bergen Kommune
- Peter D. Jost, spesialist i allmennmedisin, redaktør NEL, Trondheim